Jazz Pharmaceuticals plc
NASDAQ:JAZZ 3:32:29 PM EDT
Market Cap (Intraday) | 7.54B |
Current PE | 18.18 |
Forward PE | 6.38 |
2yr Forward PE | 5.74 |
10-Day MA | $120.95 |
50-Day MA | $122.48 |
200-Day MA | $126.84 |
Jazz Pharmaceuticals plc Stock, NASDAQ:JAZZ
Waterloo Exchange, Waterloo Road, Dublin, Dublin 4
Ireland
Phone: +353.1.634.7800
Number of Employees: 2800
Description
Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.